Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

In short, pancreatic cancer is dangerous because it usually starts quietly. But if you know the signs—like yellow skin, ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

Carol Saffran started taking Ozempic a year ago to regulate her blood sugar after other medications were ineffective. She was ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get ready for your next job interview with a free guide from ...

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

Weight-loss drugs linked to dramatically lower death rates in colon cancer patients - GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the ...